Neurocrine Biosciences, Inc.
NBIX
$94.97
-$7.91-7.69%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.08B | 1.23B | 1.04B | 1.21B | 1.03B |
| Total Receivables | 479.10M | 481.10M | 468.20M | 450.70M | 439.30M |
| Inventory | 57.40M | 45.80M | 42.50M | 37.20M | 38.30M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 112.10M | 121.70M | 120.20M | 100.50M | 97.80M |
| Total Current Assets | 1.72B | 1.88B | 1.67B | 1.80B | 1.61B |
|
|
|||||
| Total Current Assets | 1.72B | 1.88B | 1.67B | 1.80B | 1.61B |
| Net Property, Plant & Equipment | 592.00M | 337.30M | 343.00M | 346.10M | 347.30M |
| Long-term Investments | 5.70M | 6.10M | -- | -- | 5.80M |
| Goodwill | 5.70M | 6.10M | -- | -- | 5.80M |
| Total Other Intangibles | 36.50M | 34.50M | 33.50M | 34.30M | 35.50M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 495.50M | 509.90M | 477.30M | 429.10M | 406.40M |
| Total Assets | 3.72B | 3.54B | 3.31B | 3.47B | 3.25B |
|
|
|||||
| Total Accounts Payable | 110.00M | 95.70M | 107.20M | 87.30M | 133.30M |
| Total Accrued Expenses | 351.60M | 297.00M | 251.30M | 305.10M | 315.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 40.60M | 34.80M | 35.40M | 157.80M | 170.10M |
| Total Finance Division Other Current Liabilities | 5.50M | 2.20M | 4.60M | 162.70M | 35.90M |
| Total Other Current Liabilities | 5.50M | 2.20M | 4.60M | 162.70M | 35.90M |
| Total Current Liabilities | 507.70M | 429.70M | 398.50M | 712.90M | 654.80M |
|
|
|||||
| Total Current Liabilities | 507.70M | 429.70M | 398.50M | 712.90M | 654.80M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 455.10M | 251.40M | 256.20M | 252.90M | 258.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 166.20M | 135.00M | 141.10M | 120.50M | 106.30M |
| Total Liabilities | 1.13B | 816.10M | 795.80M | 1.09B | 1.02B |
|
|
|||||
| Common Stock & APIC | 2.55B | 2.62B | 2.56B | 2.50B | 2.38B |
| Retained Earnings | 29.20M | 81.10M | -48.70M | -113.70M | -157.10M |
| Treasury Stock & Other | 5.80M | 14.50M | 2.50M | 3.30M | 7.00M |
| Total Common Equity | 2.59B | 2.72B | 2.51B | 2.39B | 2.23B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.59B | 2.72B | 2.51B | 2.39B | 2.23B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.59B | 2.72B | 2.51B | 2.39B | 2.23B |
|
|
|||||
